Pemphigoïde bulleuse associée à la prise d'un inhibiteur de la dipeptidyl peptidase-4
Y Kano, M Kato - CMAJ, 2022 - Can Med Assoc
Les images cliniques sont choisies pour leur caractère particulièrement intéressant,
classique ou impressionnant. Toute soumission d'image de haute résolution claire et bien …
classique ou impressionnant. Toute soumission d'image de haute résolution claire et bien …
Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication
Y Shinohara, T Iijima, S Sakurai, T Jojima… - Clinical Case …, 2020 - Wiley Online Library
We experienced two cases of dipeptidyl peptidase‐4 (DPP‐4) inhibitor‐associated bullous
pemphigoid (BP) showing an unfavorable course despite its discontinuation. Clinicians …
pemphigoid (BP) showing an unfavorable course despite its discontinuation. Clinicians …
Three cases of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor therapy showing unfavorable outcomes despite immediate discontinuation of …
Y Shinohara, T Iijima, T Jojima, E Oohira… - Authorea …, 2020 - essopenarchive.org
An association has been reported between BP and DPP-4 inhibitors. We report three cases
of DPP-4 inhibitor-associated BP, with an unfavorable course in 2 patients despite …
of DPP-4 inhibitor-associated BP, with an unfavorable course in 2 patients despite …
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: evaluation of clinical course and treatment response
I Tzanani, I Tzachy-Suissa, A Barzilai… - Clinical and …, 2023 - academic.oup.com
Background Dipeptidyl peptidase-4 inhibitors (DPP4is), drugs used to treat type 2 diabetes
mellitus (DM2), show a significant association with bullous pemphigoid (BP) development …
mellitus (DM2), show a significant association with bullous pemphigoid (BP) development …
[PDF][PDF] PEMPHIGUS: PRISE EN CHARGE (A propos de 68 cas)
B LOUBNA - 2011 - toubkal.imist.ma
AMM: autorisation de mise sur le marché ATCD: antécédent C3: fraction 3 du complément
IFD: immuno-fluorescence direct IFI: immuno-fluorescence indirect Ig: immuno-globuline IV …
IFD: immuno-fluorescence direct IFI: immuno-fluorescence indirect Ig: immuno-globuline IV …
Pemphigoid nodularis induced by long-term use of dipeptidyl peptidase-4 inhibitors
N Norikawa, K Irie, M Ishikawa, T Hiraiwa… - Indian Journal of …, 2023 - journals.lww.com
Discussion The characteristics of the present case are i) the patient had been diagnosed as
having refractory nodular prurigo and treated as refractory nodular prurigo, for which had …
having refractory nodular prurigo and treated as refractory nodular prurigo, for which had …
Development of pemphigus vulgaris during treatment with dipeptidyl peptidase‐4 inhibitors: a case report.
K Oya, M Fujii, S Taguchi - Dermatologic Therapy, 2021 - search.ebscohost.com
Further studies are needed to elucidate the mechanism of PV onset due to DPP-4i.
Pemphigus vulgaris (PV), a rare autoimmune disease, affects the skin and mucous …
Pemphigus vulgaris (PV), a rare autoimmune disease, affects the skin and mucous …
Profil évolutif des patients atteints de pemphigoïde bulleuse au cours de la première année de traitement
V Doffoel-Hantz, A Sparsa, B Marin, H Durox… - … de Dermatologie et de …, 2009 - Elsevier
Résumé Introduction Depuis l'avènement des dermocorticoïdes d'activité très forte (DCF)
dans le traitement de la pemphigoïde bulleuse (PB) en 2002, peu d'études longitudinales se …
dans le traitement de la pemphigoïde bulleuse (PB) en 2002, peu d'études longitudinales se …
Dipeptidyl‐peptidase IV inhibitor‐associated bullous pemphigoid efficiently treated with omalizumab.
PM Garrido, MI Alexandre… - Dermatologic …, 2020 - search.ebscohost.com
Dipeptidyl-peptidase IV inhibitor-associated bullous pemphigoid efficiently treated with
omalizumab Serum IgG against BP180 titers dropped during omalizumab treatment, but …
omalizumab Serum IgG against BP180 titers dropped during omalizumab treatment, but …
[CITATION][C] Pemphigus ou pemphigoide
F Földvári - Dermatology, 1958 - karger.com
On n'est pas encore arrivé à une conception unanime ([uant aux affections bulleuses qu'il
faut classer dans le groupe des pemphigus. De nombreux auteurs attribuent plus …
faut classer dans le groupe des pemphigus. De nombreux auteurs attribuent plus …
